Steven P. Coen Ginkgo Bioworks Holdings, Inc. (DNA) insider trading activity

Steven P. Coen is Officer of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 7,664 shares of DNA, which is worth approximately $87,599. The most recent transaction as insider was on Feb 04, 2025, when has been sold 367 shares (Class A Common Stock) at a price of $13.44 per share, resulting in proceeds of $4,932. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.66K

18.71% 3M change

n/a 12M change

Total Value Held $87,599

Steven P. Coen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 04 2025	SELL Open market or private sale	$4,932 $13.44 p/Share	367 Reduced 4.57%	7,664 Class A Common Stock
Feb 03 2025	BUY Exercise of conversion of derivative security	-	743 Added 8.47%	8,031 Class A Common Stock
Jan 06 2025	SELL Open market or private sale	$3,797 $11.72 p/Share	324 Reduced 4.26%	7,288 Class A Common Stock
Jan 03 2025	BUY Exercise of conversion of derivative security	-	743 Added 8.89%	7,612 Class A Common Stock
Dec 04 2024	SELL Open market or private sale	$3,181 $9.64 p/Share	330 Reduced 4.58%	6,869 Class A Common Stock
Dec 03 2024	BUY Exercise of conversion of derivative security	-	743 Added 9.36%	7,199 Class A Common Stock
Nov 04 2024	SELL Open market or private sale	$2,524 $7.58 p/Share	333 Reduced 4.9%	6,456 Class A Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	-	743 Added 9.86%	6,789 Class A Common Stock
Oct 04 2024	SELL Open market or private sale	$2,555 $8.35 p/Share	306 Reduced 4.82%	6,046 Class A Common Stock
Oct 03 2024	BUY Exercise of conversion of derivative security	-	743 Added 10.47%	6,352 Class A Common Stock
Sep 12 2024	SELL Open market or private sale	$1,949 $6.17 p/Share	316 Reduced 5.33%	5,609 Class A Common Stock
Sep 11 2024	BUY Exercise of conversion of derivative security	-	743 Added 11.14%	5,925 Class A Common Stock
Aug 02 2024	SELL Open market or private sale	$5,070 $0.29 p/Share	17,486 Reduced 7.78%	207,318 Class A Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	-	29,746 Added 11.69%	224,804 Class A Common Stock
Jul 02 2024	SELL Open market or private sale	$4,461 $0.33 p/Share	13,520 Reduced 6.48%	195,058 Class A Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	-	29,746 Added 12.48%	208,578 Class A Common Stock
Jun 03 2024	SELL Open market or private sale	$7,392 $0.55 p/Share	13,440 Reduced 6.99%	178,832 Class A Common Stock
May 31 2024	BUY Exercise of conversion of derivative security	-	29,745 Added 13.4%	192,272 Class A Common Stock
May 02 2024	SELL Open market or private sale	$110,819 $0.84 p/Share	131,928 Reduced 44.8%	162,527 Class A Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	-	294,455 Added 50.0%	294,455 Class A Common Stock

SPC

Steven P. Coen

Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Value

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA

Account